Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gonal-f Dosing in Chronic Anovulation
NCT01081626Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Mar 2009
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of follitropin alfa in infertility, anovulation, sponsored by Merck KGaA. Started Mar 2009; status: completed.
02
Drugs
follitropin alfa
03
Conditions
infertilityanovulation
Beyond the preview
Go deeper on NCT01081626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081626.